Recent

% | $
Quotes you view appear here for quick access.

ArQule Inc. Message Board

  • stev_26_2000 stev_26_2000 Nov 4, 2012 10:59 AM Flag

    ARQL at 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

    November 6-9th.

    Pharma, I would like to know your thoughts on these abstracts. I have my ideas but not being a scientist I won't comment. Pharma, I must say your writing style and thought process reminds me a lot of someone that used to post on these boards several years back.....MH00034. I miss hearing from him.

    Here are the two posters ARQL will have. First one on Nov 8 is: Combination Effect of Tivantinib with Erlotinib On Cell Proliferation, C-Met Signals and Apoptosis in a Human Non-small Cell Lung Cancer Cell Line

    Second one on Nov 9th is: Relationship Between Tumor MET Expression and Clinical Outcomes in Cancer Patients Treated with Tivantinib

    If you Google the congress you can see the abstracts in the searchable program.

    Steve

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ARQL
1.65-0.03(-1.79%)May 26 4:00 PMEDT